Endocrinology · Resistance to Thyroid Hormone

Diagnosis and Making Sense of Your Lab Results

At a Glance

Resistance to thyroid hormone is suspected when free T4 is high and free T3 is often high or high-normal while TSH is normal or slightly high. Doctors rule out lab errors, binding protein problems, and a TSH-producing pituitary tumor; a negative genetic test does not always exclude RTH.

Confirming a diagnosis of Resistance to Thyroid Hormone (RTH) is a detailed process that involves ruling out “look-alike” conditions and lab errors. Because the treatment for RTH is very different from other thyroid conditions, your care team must be certain of the diagnosis before moving forward ^[1].

The Classic Laboratory Profile

In most cases of RTH-Beta (RTH $\beta$ ), blood tests show a very specific and unusual pattern. This is often called the “biochemical signature” of the condition ^[2]:

Free T4 (Thyroxine): Persistently elevated.
Free T3 (Triiodothyronine): Often elevated, or at the very top of the normal range ^[3].
TSH (Thyroid-Stimulating Hormone): Normal or slightly elevated.

In a typical person without RTH, high levels of T4 and T3 would cause the brain to shut down TSH production (a “suppressed” TSH). In RTH, the brain is “blind” to these high levels, so it keeps sending out TSH as if the body is still hungry for hormone ^[4].

Ruling Out Lab Interference

Before assuming the results are due to a rare genetic condition, doctors must ensure the lab results are accurate. Several factors can create a “fake” RTH pattern on a lab report:

Biotin Interference: High doses of biotin can interfere with many lab assays, producing falsely high thyroid-hormone results with falsely low TSH. You should always disclose biotin use to your doctor, as the washout interval depends on the dose, your kidney function, and specific laboratory guidance ^[5]^[6].
Assay Antibodies: Some people have “sticky” antibodies (heterophile antibodies) in their blood that interfere with the chemicals used in the lab, leading to incorrect readings ^[1].
Binding Protein Abnormalities: Conditions like Familial Dysalbuminemic Hyperthyroxinemia (FDH) involve a variant in a carrier protein that grabs onto thyroid hormones too tightly, causing “false” elevations in standard tests even though the patient is perfectly healthy ^[7]^[8].

To resolve these, your doctor might repeat the tests using a different lab method or a highly specialized technique called equilibrium dialysis, which is less prone to these errors ^[7]^[9].

RTH vs. Pituitary Tumors (TSHomas)

The most challenging part of the diagnosis is distinguishing RTH from a TSH-secreting pituitary adenoma (TSHoma), a rare, usually benign tumor in the brain’s pituitary gland that pumps out TSH ^[10]. Diagnosis relies on a specialist-led, multimodal evaluation rather than a fixed sequence of tests.

Feature	Resistance to Thyroid Hormone (RTH)	Pituitary Tumor (TSHoma)
Family History	Often present in parents/siblings ^[11].	Usually no family history.
Alpha-Subunit & SHBG	Typically normal, but can be affected by other illnesses or medications.	Often elevated, but not exclusively ^[12]^[13].
T3-Suppression Test	TSH may drop ^[14].	TSH typically does not drop ^[10]. (Note: this is a specialist test and may be unsafe in some patients).

MRI Considerations: Pituitary imaging is considered when the biochemical and clinical evidence warrants it. About 10–20% of healthy people have tiny, harmless spots on their pituitary gland called incidentalomas ^[10]. If an RTH patient has one, a doctor might mistake it for a TSHoma. Surgery is not recommended from an MRI image alone, but is considered only after integrated biochemical, clinical, and imaging review ^[15].

The Role of Genetic Testing

Genetic testing can look for mutations in the THRB gene (for RTH-Beta) or the THRA gene (for RTH-Alpha).

Positive Result: A pathogenic or likely pathogenic variant strongly supports the diagnosis.
Negative Result: This does not completely rule out RTH. About 15% of people with clear clinical signs of RTH-Beta do not have a mutation found on standard THRB tests ^[16]. This might require technical review, deletion/duplication analysis, broader genetic evaluation, or expert clinical reassessment. Mosaicism (where the mutation is only in some cells) is one possibility, but not the only routine explanation ^[16].
Variant of Uncertain Significance (VUS): This means a change was found in your DNA, but scientists aren’t sure yet if it’s causing the condition ^[17]. Testing your parents or children can help clarify the context, but parental testing alone cannot prove that a VUS is disease-causing ^[18].

Common questions in this guide

What thyroid test pattern can suggest resistance to thyroid hormone?

In RTH-Beta, free T4 is usually persistently high, free T3 is often high or at the upper end of normal, and TSH is normal or slightly high. This differs from the usual response to high thyroid hormone levels, which is a suppressed TSH. The pattern raises suspicion but does not confirm the diagnosis by itself.

Can biotin supplements distort my thyroid blood tests?

Yes. High-dose biotin, including biotin in some hair, skin, and nail supplements, can cause falsely high thyroid-hormone results and falsely low TSH. Tell your clinician about biotin use before testing; the appropriate washout interval depends on the dose, kidney function, and the laboratory's instructions.

What other problems can make my results look like RTH?

Assay-interfering antibodies and familial dysalbuminemic hyperthyroxinemia can produce misleading thyroid-hormone results. Doctors may repeat testing with a different assay or use equilibrium dialysis, a specialized method that is less vulnerable to some testing errors. These checks help distinguish a laboratory artifact from true thyroid hormone resistance.

How is RTH distinguished from a TSH-secreting pituitary tumor?

Clinicians compare the blood-test pattern with family history, alpha-subunit and SHBG (sex hormone-binding globulin) results, selected suppression testing, symptoms, and pituitary imaging. A T3-suppression test may show whether TSH falls, but it is a specialist test and may be unsafe for some people. The diagnosis should be based on the combined evidence, not one result.

Could a pituitary spot on my MRI be mistaken for a TSHoma?

Yes. Small, harmless pituitary spots called incidentalomas occur in about 10% to 20% of healthy people and can be mistaken for a TSH-secreting tumor. MRI findings must be interpreted together with the clinical picture and hormone tests, and surgery should not be based on the image alone.

Can a negative genetic test rule out resistance to thyroid hormone?

No. About 15% of people with clear clinical features of RTH-Beta do not have a mutation detected by standard THRB testing. A specialist may consider technical review, deletion or duplication analysis, broader genetic testing, or clinical reassessment.

What does a variant of uncertain significance mean on my genetic report?

A variant of uncertain significance, or VUS, is a DNA change whose role in disease is not known. Testing parents or children may provide helpful family context, but parental testing alone cannot prove that the variant causes resistance to thyroid hormone. A VUS should not be treated as a confirmed diagnosis.

Get notified when new evidence is published on thyroid hormone resistance syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (18)

1
Approach to the Patient With Raised Thyroid Hormones and Nonsuppressed TSH.
Moran C, Schoenmakers N, Halsall D, et al.
The Journal of clinical endocrinology and metabolism 2024; (109(4)):1094-1108 doi:10.1210/clinem/dgad681.
PMID: 37988295
2
Syndromes of Resistance to Thyroid Hormone Action.
Persani L, Campi I
Experientia supplementum (2012) 2019; (111()):55-84 doi:10.1007/978-3-030-25905-1_5.
PMID: 31588528
3
Human Genetics of Thyroid Hormone Receptor Beta: Resistance to Thyroid Hormone Beta (RTHβ).
Pappa T, Refetoff S
Methods in molecular biology (Clifton, N.J.) 2018; (1801()):225-240 doi:10.1007/978-1-4939-7902-8_18.
PMID: 29892828
4
Reduced pituitary size in subjects with mutations in the THRB gene and thyroid hormone resistance.
Heldmann M, Chatterjee K, Moran C, et al.
Endocrine connections 2022; (11(1)).
PMID: 34860176
5
Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature.
Elston MS, Sehgal S, Du Toit S, et al.
The Journal of clinical endocrinology and metabolism 2016; (101(9)):3251-5 doi:10.1210/jc.2016-1971.
PMID: 27362288
6
Apparent Hyperthyroidism Caused by Biotin-Like Interference from IgM Anti-Streptavidin Antibodies.
Lam L, Bagg W, Smith G, et al.
Thyroid : official journal of the American Thyroid Association 2018; (28(8)):1063-1067 doi:10.1089/thy.2017.0673.
PMID: 29808739
7
Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease.
Khoo S, Lyons G, Solomon A, et al.
Endocrinology, diabetes & metabolism case reports 2020; (2020()).
PMID: 32101523
8
Clinical recognition and evaluation of patients with inherited serum thyroid hormone-binding protein mutations.
Mimoto MS, Refetoff S
Journal of endocrinological investigation 2020; (43(1)):31-41 doi:10.1007/s40618-019-01084-9.
PMID: 31352644
9
Familial Dysalbuminemic Hyperthyroxinemia as a Cause for Discordant Thyroid Function Tests.
Ting MJM, Zhang R, Lim EM, et al.
Journal of the Endocrine Society 2021; (5(4)):bvab012 doi:10.1210/jendso/bvab012.
PMID: 33728390
10
The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience.
Campi I, Covelli D, Moran C, et al.
Frontiers in endocrinology 2020; (11()):432 doi:10.3389/fendo.2020.00432.
PMID: 32733382
11
Thyroid Hormone Resistance: Multicentrical Case Series Study.
Santos Mata MA, Ariza Jimenez AB, Macias Lopez F, de la Camara Moraño C
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2022; (54(2)):67-75 doi:10.1055/a-1725-8533.
PMID: 35130567
12
A case of TSH-secreting pituitary adenoma with cyclic fluctuations in serum TSH levels.
Okuma H, Hashimoto K, Ohashi T, et al.
Endocrine journal 2018; (65(7)):737-746 doi:10.1507/endocrj.EJ18-0006.
PMID: 29695647
13
Ectopic Thyrotropin-Secreting Tumor in the Nasopharynx Causing Central Hyperthyroidism.
Phylactou M, Dixon L, Rennie C, et al.
JCEM case reports 2025; (3(1)):luae250 doi:10.1210/jcemcr/luae250.
PMID: 39817150
14
Can a novel drug dose be used for T3 suppression test?
Çetin S, Güven M, Bolayır B, et al.
Endocrine 2023; (82(3)):586-589 doi:10.1007/s12020-023-03445-0.
PMID: 37428297
15
A Novel Thyroid Hormone Receptor Beta Gene Mutation (G251V) in a Thai Patient with Resistance to Thyroid Hormone Coexisting with Pituitary Incidentaloma.
Sriphrapradang C, Srichomkwun P, Refetoff S, Mamanasiri S
Thyroid : official journal of the American Thyroid Association 2016; (26(12)):1804-1806 doi:10.1089/thy.2016.0450.
PMID: 27758132
16
Clinically Symptomatic Resistance to Thyroid Hormone β Syndrome Because of THRB Gene Mosaicism.
Donnars A, Leplat A, Grosheny C, et al.
The Journal of clinical endocrinology and metabolism 2022; (107(9)):e3548-e3552 doi:10.1210/clinem/dgac347.
PMID: 35689814
17
A Novel G385E Variant in the Cold Region of the T3-Binding Domain of Thyroid Hormone Receptor Beta Gene and Investigations to Assess Its Clinical Significance.
Korwutthikulrangsri M, Dosiou C, Dumitrescu AM, Refetoff S
European thyroid journal 2019; (8(6)):293-297 doi:10.1159/000503860.
PMID: 31934554
18
Apparent resistance to thyroid hormones: From biological interference to genetics.
Dieu X, Sueur G, Moal V, et al.
Annales d'endocrinologie 2019; (80(5-6)):280-285 doi:10.1016/j.ando.2019.06.005.
PMID: 31590893

This page explains how clinicians evaluate suspected resistance to thyroid hormone and interpret lab results for informational purposes only; it is not medical advice. An endocrinologist or other qualified clinician should interpret your results and decide whether further testing is needed.

Guide Contents